Quantum Biopharma Ltd Cls B Subordinate Voting S (QNTM.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 08-2017 | |
| Sales | 0 | 197 | 65 | 21 | 0 |
| Cost of Goods | N/A | 2,039 | N/A | N/A | N/A |
| Gross Profit | N/A | -1,843 | N/A | N/A | N/A |
| Operating Expenses | 30,601 | 25,979 | 18,622 | 2,823 | 19 |
| Operating Income | -30,601 | -27,821 | -18,557 | -2,803 | -19 |
| Interest Expense | 236 | 158 | N/A | N/A | N/A |
| Other Income | 2,385 | -11,839 | 1,883 | 0 | 0 |
| Pre-tax Income | -28,452 | -39,818 | -16,674 | -2,803 | -19 |
| Net Income Continuous | -28,452 | -39,818 | -16,674 | -2,803 | -19 |
| Net Income Discontinuous | -3,348 | N/A | N/A | N/A | N/A |
| Net Income | $-31,800 | $-39,818 | $-16,674 | $-2,803 | $-19 |
| EPS Basic Total Ops | -171.60 | -366.73 | -182.26 | -27.75 | -0.19 |
| EPS Basic Continuous Ops | -153.40 | -366.73 | -182.26 | N/A | N/A |
| EPS Basic Discontinuous Ops | -18.20 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -171.62 | -366.73 | -182.26 | -27.75 | -0.19 |
| EPS Diluted Continuous Ops | -153.55 | -366.73 | -182.26 | N/A | N/A |
| EPS Diluted Discontinuous Ops | -18.20 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-24,316 | $-37,251 | $-18,423 | $-2,803 | $-19 |